Betapharm Dr. Reddy’s

Address: Kobelweg 95, 86156 Augsburg,Germany

Tel: +49 (0)800 7488100

Web: http://www.betapharm.de/

Company description

Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company. As a fully integrated pharmaceutical company, our purpose is to provide affordable and innovative medicines through our three core businesses: Pharmaceutical Services and Active Ingredients; Global Generics; and Proprietary Products.

Our products are marketed globally, with a focus on India, US, Europe and Russia. Dr. Reddy’s conducts NCE research in the areas of metabolic disorders, cardiovascular indications, anti-infectives and inflammation.

betapharm GmbH:

Founded in 1993 in Augsburg, betapharm generics (sells patent medicines) and is one of the leading generic companies in Germany. In March 2004 betapharm was sold to the British financial investor 3i. Since March 2006 betapharm belongs to the international pharmaceutical company Dr. Reddy’s Laboratories, headquartered in Hyderabad, India.

The product range of betapharm includes over 150 active ingredients in over 900 commercial forms and covers all major indications of the common cold to severe cardiovascular disease. In the case of prescription medicines focuses on the areas of cardiovascular, neurology and pain / palliative. The treatment of pain is also in the non-prescription drugs from betapharm in focus.

Products and services